Tuesday, March 16, 2021 3:09:55 PM
We were formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination.
Our efforts to identify a prospective target business will not be limited to any particular industry or geographic region, although we intend to focus our search on target healthcare businesses operating in North America.
Jagi Gill, PhD, our Chief Executive Officer, has more than 20 years of healthcare investment and general management experience. From 2017 to 2020, he served as the Vice-President of Business Development and General Manager of AcuVentures, a business unit within Acumed LLC, which is a market leader in the orthopedic sector with particular strength in the upper extremity fracture repair and trauma market segments.
As the General Manager, Dr. Gill led two business units, Rib Fixation and the Soft Tissue Repair, with responsibilities for product development, sales, marketing and profitability.
Under his leadership, the business units grew 2-3x faster than their market segment. In addition to general management responsibilities, Dr. Gill was involved in sourcing, closing and integrating four acquisitions within the orthopedic sector for Acumed.
These transactions ranged from technology acquisitions serving as tuck-in product integrations to stand alone companies with global revenue.
Recent VHAQ News
- Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success - Updated • GlobeNewswire Inc. • 05/03/2024 12:00:00 PM
- Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success • GlobeNewswire Inc. • 05/02/2024 06:15:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 04/01/2024 08:46:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2024 08:45:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/29/2024 12:00:26 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 03/27/2024 10:39:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2024 10:36:49 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/01/2024 08:18:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 10:00:23 PM
- VIVEON HEALTHCARE ACQUISITION CORP. CONFIRMS COMMITMENT TO PROCEED WITH BUSINESS COMBINATION PROCESS • GlobeNewswire Inc. • 02/27/2024 09:45:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/21/2024 09:48:57 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 06:18:24 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 10:11:56 PM
- VIVEON HEALTHCARE ACQUISITION CORP CONFIRMS BUSINESS COMBINATION • GlobeNewswire Inc. • 02/01/2024 02:30:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/05/2024 09:45:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:45:22 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 12/29/2023 09:48:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:47:50 PM
- Viveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSE • GlobeNewswire Inc. • 12/27/2023 10:23:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 10:00:12 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 11/22/2023 09:46:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:45:33 PM
- VIVEON HEALTH ACQUISITION CORP. RECEIVED AUDIT OPINION WITH GOING CONCERN EXPLANATION • GlobeNewswire Inc. • 09/15/2023 08:49:57 PM
- Viveon Healthcare Increases Consideration Offered to Clearday Shareholders • GlobeNewswire Inc. • 09/05/2023 12:30:00 PM
- Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement • GlobeNewswire Inc. • 08/29/2023 04:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM